BAYERCROP · NSE
Bayer Cropscience Limited
₹3,779.5
-2.93% (-₹113.9)
Prev. close
₹3,893.4
Volume
87,483
Delivery %
69.3%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Bayer Cropscience Limited
Bayer CropScience Limited, together with its subsidiaries, engages in the agriculture business in India, Germany, Bangladesh, and internationally. The company manufactures, sells, and distributes agrochemical products, including insecticides, fungicides, herbicides, seed treatment solutions, and biologicals; produces, sells, and distributes hybrid corn seeds, as well as rice, fruits, and vegetables; and integrates digital farming solutions, such as remote sensing, artificial intelligence, IoT, drones, and data analytics. It also offers medicines for various therapeutic areas comprising cardiology, diabetes, kidney health, women's health, oncology, ophthalmology, and radiology; and over-the-counter products, including analgesics, nutrition, allergy, dermatology, and digestives. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.
Details
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Mr. Simon-Thorsten Wiebusch
Headquarters
Thane
Employees
1,074
Website
bayer.inExchange
View on NSE ↗Key stats
Market cap
₹16,985.86 Cr
P/E ratio (TTM)
23.2
Dividend yield
3.85%
EPS (TTM)
₹162.74
Beta (1Y · daily vs NIFTY 50)
0.41
Beta (5Y · monthly vs NIFTY 50)
0.88
Shares float
1.22 Cr
EPS · quarter ended Jun 2026
₹71.56
Upcoming earnings
05 Nov 2026
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 3.9% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹4,261.30 Cr | ₹4,734.40 Cr | ₹4,944.90 Cr | ₹4,892.10 Cr | ₹5,314.10 Cr | ₹5,498.00 Cr | |
| EBITDA | ₹875.50 Cr | ₹865.70 Cr | ₹1,091.90 Cr | ₹1,035.00 Cr | ₹809.30 Cr | ₹968.70 Cr |
| ₹493.10 Cr | ₹645.30 Cr | ₹758.20 Cr | ₹740.50 Cr | ₹568.00 Cr | ₹689.20 Cr | |
| Diluted EPS | ₹109.72 | ₹143.58 | ₹168.71 | ₹164.77 | ₹126.38 | ₹153.35 |
Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹4,239.30 Cr | ₹4,352.90 Cr | ₹4,678.60 Cr | ₹4,597.10 Cr | ₹5,245.90 Cr | ₹5,699.40 Cr | |
| ₹26.30 Cr | ₹86.40 Cr | ₹73.50 Cr | ₹47.10 Cr | ₹105.10 Cr | ₹81.80 Cr | |
| Stockholders' equity | ₹2,550.30 Cr | ₹2,524.30 Cr | ₹2,712.10 Cr | ₹2,849.40 Cr | ₹2,850.40 Cr | ₹2,965.70 Cr |
Fixed assets, CWIP have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated. Current (short-term) debt has no filed figures within the years shown — no further verified source is available, so every year here is left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹609.30 Cr | ₹951.60 Cr | ₹262.00 Cr | ₹1,078.50 Cr | |
| Investing cash flow | — | — | ₹83.30 Cr | ₹40.00 L | ₹85.60 Cr | ₹72.50 Cr |
| — | — | ₹-613.20 Cr | ₹-656.30 Cr | ₹-619.40 Cr | ₹-623.80 Cr | |
| Capital expenditure | — | — | ₹-77.30 Cr | ₹-45.70 Cr | ₹-43.40 Cr | ₹-64.50 Cr |
| End cash position | — | — | ₹860.30 Cr | ₹1,156.50 Cr | ₹885.00 Cr | ₹1,412.70 Cr |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Basic Materials
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| UltraTech Cement Limited | ₹3.17 L Cr | ₹11,014 | 36.9 | 4.13 | 10.7% | 0.31 | +16.6% | -12.8% |
| JSW Steel Limited | ₹3.06 L Cr | ₹1,275.6 | 12.4 | 3.06 | 22.3% | 1.19 | +9.3% | +13.8% |
| Hindustan Zinc Limited | ₹2.42 L Cr | ₹596 | 14.2 | 10.69 | 61.1% | 0.39 | +18.6% | +31.0% |
| Asian Paints Limited | ₹2.35 L Cr | ₹2,451.3 | 49.3 | 11.01 | 20.2% | 0.18 | +5.1% | -1.1% |
| Tata Steel Limited | ₹2.28 L Cr | ₹187.29 | 20.7 | 2.23 | 10.6% | 0.90 | +6.2% | +9.3% |
| Hindalco Industries Limited | ₹2.18 L Cr | ₹986.5 | 13.3 | 1.59 | 9.8% | 0.73 | +15.0% | +31.5% |
| Grasim Industries Limited | ₹2.15 L Cr | ₹3,209.2 | 37.9 | 2.08 | 4.8% | 2.20 | +18.2% | +11.5% |
| Solar Industries India Limited | ₹1.71 L Cr | ₹18,815 | 86.1 | 27.25 | 26.7% | 0.29 | +30.6% | +27.0% |
| Vedanta Aluminium Metal Limited | ₹1.60 L Cr | ₹416.5 | 42.1 | — | — | — | — | — |
| Pidilite Industries Limited | ₹1.58 L Cr | ₹1,572.1 | 59.8 | 14.58 | 22.6% | 0.04 | +11.1% | -48.5% |
| JINDAL STEEL LIMITED | ₹1.11 L Cr | ₹1,103 | 41.1 | 2.19 | 6.6% | 0.44 | +5.5% | +4.7% |
| Bayer Cropscience Limited | ₹17,497.75 Cr | ₹3,779.5 | 23.9 | 5.90 | 23.2% | 0.03 | +3.5% | -27.3% |
Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 24
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
25 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Bayer CropScience Q4 FY26 results: net profit rises 13% as total income increases
Bayer CropScience Ltd reported a 13% rise in Q4 FY26 net profit to Rs 162.1 crore, driven by a higher total income of Rs 1,147.4 crore. For the full FY26, net profit increased to Rs 689.2 crore and total income reached Rs 5,770 crore, despite some Kharif disruptions. The company's board also recommended a final dividend of Rs 60 per equity share.